Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arhalofenate + Febuxostat in Gout
NCT01416402Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arhalofenate in gout, hyperuricemia, sponsored by Gilead Sciences. Started Aug 2011; status: completed.
02
Drugs
arhalofenate
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT01416402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416402.